Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GnRH agonist for endometrial preparation before frozen embryo transfer in women with repeated implantation failure
IRCT201708292604N3Phase 3Completed
- Sponsor
- Yazd Reproductive Sciences Institute
- Start
- Aug 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of DehydraTECH-estrogen and progesterone in Recurrent Implantation Failure (RIF) and infertility (2 arms), sponsored by Yazd Reproductive Sciences Institute. Primary endpoints: chemical pregnancy, clinical pregnancy and 1 more. Started Aug 2017; status: completed.
02
Drugs
DehydraTECH-estrogenprogesterone
03
Conditions
Recurrent Implantation Failure (RIF)infertility
Beyond the preview
Go deeper on IRCT201708292604N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201708292604N3.